Ionis Pharmaceuticals, Inc.
MODULATORS OF COMPLEMENT FACTOR B

Abstract:

The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.